Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patients

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Weinstock Guttman, Bianca ^a   Zivadinov, Robert ^a   Cutter, Gary ^b   Tamaño Blanco, Miriam ^c   Marr, Karen ^a   Badgett, Darlene ^c   Carl, Ellen ^a   Elfadil, Makki ^a   Kennedy, Cheryl ^a   Benedict, Ralph H B ^a   Ramanathan, Murali ^a,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; HLA DRB1*1501, HUMAN; HLA-DRB1*1501, HUMAN;

ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; ALLELE; CASE CONTROL STUDY; COLOR ULTRASOUND FLOWMETRY; DISEASE COURSE; ECHOGRAPHY; GENETICS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SPINAL CORD; VASCULARIZATION; VEIN INSUFFICIENCY;

ADULT; ALLELES; CASE-CONTROL STUDIES; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SPINAL CORD; ULTRASONOGRAPHY, DOPPLER, COLOR; VENOUS INSUFFICIENCY;

EID: 79951872790     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016802     Document Type: Article

References (29)

1. Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Gianesini S, et al. (2009) A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg 50: 1348-1358 e1341-1343.
2. Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Tacconi G, et al. (2009) Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 80: 392-399.
3. Zamboni P, Menegatti E, Galeotti R, Malagoni AM, Tacconi G, et al. (2009) The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci 282: 21-27.
4. Singh AV, Zamboni P, (2009) Anomalous venous blood flow and iron deposition in multiple sclerosis. J Cereb Blood Flow Metab 29: 1867-1878.
5. Zamboni P, (2006) The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med 99: 589-593.
6. Doepp F, Paul F, Valdueza JM, Schmierer K, Schreiber SJ, (2010) No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol 68: 173-183.
7. Sundstrom P, Wahlin A, Ambarki K, Birgander R, Eklund A, et al. (2010) Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann Neurol 68: 255-259.
8. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, et al. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357: 851-862.
9. Ramagopalan SV, Anderson C, Sadovnick AD, Ebers GC, (2007) Genomewide study of multiple sclerosis. N Engl J Med 357: 2199-2200; author reply 2200-2191.
10. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL, (2008) The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 9: 516-526.
11. Kantarci OH, (2008) Genetics and natural history of multiple sclerosis. Semin Neurol 28: 7-16.
12. De Jager PL, Chibnik LB, Cui J, Reischl R, Lehr S, et al. (2009) Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurology 8: 1111-1119.
13. Ferlini A, Bovolenta M, Neri M, Gualandi F, Balboni A, et al. (2010) Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis. BMC Med Genet 11: 64.
14. Zivadinov R, Marr K, Cutter G, Ramanathan M, Benedict RHB, et al. (2010) Prevalence, sensitivity and specificity of chronic cerebrospinal venous insufficiency in multiple sclerosis Neurology In press.
15. Dickinson JL, Perera DI, van der Mei AF, Ponsonby AL, Polanowski AM, et al. (2009) Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction. Mult Scler 15: 563-570.
16. Lublin FD, Reingold SC, (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46: 907-911.
17. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127.
18. Vasconcelos CC, Fernandez O, Leyva L, Thuler LC, Alvarenga RM, (2009) Does the DRB1*1501 allele confer more severe and faster progression in primary progressive multiple sclerosis patients? HLA in primary progressive multiple sclerosis. J Neuroimmunol 214: 101-103.
19. DeLuca GC, Ramagopalan SV, Herrera BM, Dyment DA, Lincoln MR, et al. (2007) An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc Natl Acad Sci U S A 104: 20896-20901.
20. Weatherby SJ, Thomson W, Pepper L, Donn R, Worthington J, et al. (2001) HLA-DRB1 and disease outcome in multiple sclerosis. J Neurol 248: 304-310.
21. Hojnacki D, Zamboni P, Lopez-Soriano A, Galleotti R, Menegatti E, et al. (2010) Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls. Int Angiol 29: 127-139.
22. Zivadinov R, Lopez-Soriano A, Weinstock-Guttman B, Schirda C, Magnano C, et al. (2010) Use of magnetic resonance venography for characterization of the extra-cranial venous system in patients with multiple sclerosis and healthy controls. Radiology In press.
23. Zivadinov R, Galleotti R, Hojnacki D, Menegatti E, Dwyer MG, et al. (2010) Value of magnetic resonance venography for detection of internal jugular vein anomalies in multiple sclerosis. A pilot longitudinal study Am J Neuroradiol (in press). Am J Neuroradiol In press.
24. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D, (2005) The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 15: 175-184.
25. Koc Z, Ulusan S, Oguzkurt L, Tokmak N, (2007) Venous variants and anomalies on routine abdominal multi-detector row CT. Eur J Radiol 61: 267-278.
26. Khatri VP, Wagner-Sevy S, Espinosa MH, Fisher JB, (2001) The internal jugular vein maintains its regional anatomy and patency after carotid endarterectomy: a prospective study. Ann Surg 233: 282-286.
27. Brouillard P, Vikkula M, (2007) Genetic causes of vascular malformations. Hum Mol Genet 16 Spec No. 2: R140-149.
28. Limaye N, Boon LM, Vikkula M, (2009) From germline towards somatic mutations in the pathophysiology of vascular anomalies. Hum Mol Genet 18: R65-74.
29. Hu HT, Huang YH, Chang YA, Lee CK, Jiang MJ, et al. (2008) Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression. J Invest Dermatol 128: 2325-2333.